Ultragenyx Pharmaceutical Stock News & Updates

[WKN: A1XCY0 | Symbol: RARE]
Ultragenyx Pharmaceutical

Bessent’s Billion Buyback Fizzles, the Bond Rally Suffocates, and an Oil Shock After Trump’s Threat of Economic Warfare Against Iran Pushes Brent Towards $95 – Wall Street Heads Towards Its Fifth Consecutive Loss,While Walmart’s Weakest Growth in Over Six Years Raises New Economic Concerns – Bitcoin Breaks Above 70,000 for the First Time in Two Months

Ultragenyx: The first FDA approval in the gene therapy segment - Experts raise the price target to $103!

The US health authority FDA has granted accelerated approval for the gene therapy Genglycos by Ultragenyx...

Top 5 Biopharma Stocks for the new Health era

Currently, our screening includes 23 biopharma stocks that have risen by at least 10% in the last 20...

  • ‹
  • 1
  • ›